New drug combo could help you breathe easier at night
NCT ID NCT05350215
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This early-phase study tests whether a combination of two drugs—atomoxetine and DAW2022—can reduce the severity of obstructive sleep apnea (OSA) in 18 adults with moderate-to-severe OSA. The goal is to find a better-tolerated alternative to current treatments by measuring breathing pauses and oxygen levels during sleep.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02135, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do current sleepiness tests work for kids? a new study puts them to the test
- Remote monitoring may boost sleep apnea therapy adherence
- Could a mouthpiece replace the CPAP machine for sleep apnea?
- Can a new painkiller prevent breathing crises after surgery?
- Personalizing sleep apnea treatment: a step toward better CPAP outcomes
- A blood test for sleep apnea? MicroRNAs may hold the key